Lv1
10 积分 2025-10-15 加入
Best Practices and Considerations for Clinical Pharmacology and Pharmacometric Aspects for Optimal Development of CAR‐T and TCR‐T Cell Therapies: An Industry Perspective
12小时前
已完结
Neoantigen-targeted TCR-T cell therapy for solid tumors: How far from clinical application
1天前
已完结
HBV antigen as a tumour antigen in adoptive TCR-T cell therapy for HBV-related HCC: rationale and clinical effectiveness
1天前
已完结
Targeting the roots of myeloid malignancies with T cell receptors
2天前
已完结
Recent Achievements about Targeted Alpha Therapy-Based Targeting Vectors and Chelating Agents
2个月前
已完结
Radiolabeled Antibody-Drug Conjugates in the Treatment of Solid Tumors
2个月前
已完结
Preclinical Development of CAR T Cells with Antigen-Inducible IL18 Enforcement to Treat GD2-Positive Solid Cancers
2个月前
已完结
Obecabtagene Autoleucel: First Approval
2个月前
已完结